Add like
Add dislike
Add to saved papers

Dissolution of realgar by Acidithiobacillus ferrooxidans in the presence and absence of zerovalent iron: Implications for remediation of iron-deficient realgar tailings.

Chemosphere 2018 October
Realgar (As4 S4 )-rich tailings are iron-deficient arsenical mine wastes. The mechanisms and products of the dissolution of realgar by Acidithiobacillus ferrooxidans (A. ferrooxidans) in the presence (0.2 g and 2 g) and absence of zerovalent iron (ZVI) are investigated for three stages (each of 7 d with fresh A. ferrooxidans medium addition between the stages). SEM-EDX, FTIR, XPS and selective extraction analysis are used to characterize the solid-phase during the experiments. ZVI addition causes the systems to become more acid-generating, although pH increases are observed in the first day due to ZVI dissolution. Arsenic is released to solution due to realgar oxidation (∼30 mg L-1 in the 0 g ZVI system in Stage I), but low concentrations are observed in the ZVI-added systems (<5 mg L-1 ) and in Stages II and III of the 0 g ZVI system. As(III) dominates the released As(T) at day 1 (83-89% of As(T)), but is largely oxidized to As(V) at day 7 of each stage (53-98% of As(T)). Arsenic attenuation is attributed to the formation of mixed As-Fe oxyhydroxides and oxyhydroxy sulfates that take up released arsenic and are abundant in the 2.0 g ZVI system, and to passivation of the realgar surface. Consequently, a new strategy that combines A. ferrooxidans and exogenous ZVI addition for treating in-situ iron-deficient realgar-rich tailings is proposed, although its long-term effects need to be monitored.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app